What is Brighthouse's earnings per share (EPS)?

Brighthouse (BHFAL) reported diluted earnings per share of $5.71 for fiscal year 2025. This represents a 23.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Brighthouse Financials

BHFAL

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Brighthouse (BHFAL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BHFAL FY2025 2026-04-22

BHFAL’s balance-sheet economics dominate: a $241.8B asset base produced just $331M of FY2025 profit, so shareholder returns at this scale hinge on leverage, not sales.

What looks like a healthier capital structure is mostly an equity-rebuild story, not a debt-reduction story. Debt barely moved, yet debt-to-equity improved from 63.9% to 46.6% by FY2025, so the better leverage ratio came from a thicker loss-absorbing cushion rather than from materially lower borrowing.

Cash conversion only recently stopped contradicting reported earnings: FY2024 showed $286M of net income but -$290M of operating cash flow. FY2025 then paired $331M of profit with $259M of operating cash flow, indicating that annual earnings are being shaped by balance-sheet movements as much as by recurring cash generation.

Traditional term debt is not the main funding pressure point: in FY2025, cash of $5.4B exceeded long-term debt of $3.2B. But the business still runs on a very thin equity layer, which is why a 0.1% ROA translated into a 4.9% ROE and made modest asset-level results look more meaningful to shareholders.

Financial Health Signals

Financial Profile 30/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Brighthouse's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

Brighthouse's revenue surged 43.2% year-over-year to $6.8B, reflecting rapid business expansion. This strong growth earns a score of 80/100.

Leverage

Brighthouse carries a low D/E ratio of 0.47, meaning only $0.47 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 93/100, indicating a strong balance sheet with room for future borrowing.

Returns

Brighthouse generates a 4.9% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 9/100. This is down from 5.8% the prior year.

Piotroski F-Score Neutral

6/9

Brighthouse passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

0.78x

For every $1 of reported earnings, Brighthouse generates $0.78 in operating cash flow ($259.0M OCF vs $331.0M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$6.8B

YoY+43.2%

5Y CAGR-4.5%

10Y CAGR-2.7%

Brighthouse generated $6.8B in revenue in fiscal year 2025. This represents an increase of 43.2% from the prior year.

EBITDA

N/A

Net Income

$331.0M

YoY+15.7%

10Y CAGR-11.5%

Brighthouse reported $331.0M in net income in fiscal year 2025. This represents an increase of 15.7% from the prior year.

EPS (Diluted)

$5.71

YoY+23.1%

Brighthouse earned $5.71 per diluted share (EPS) in fiscal year 2025. This represents an increase of 23.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$5.4B

YoY+6.8%

5Y CAGR+5.6%

10Y CAGR+13.1%

Brighthouse held $5.4B in cash against $3.2B in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

57M

YoY-2.5%

5Y CAGR-8.3%

Brighthouse had 57M shares outstanding in fiscal year 2025. This represents a decrease of 2.5% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

4.9%

YoY-1.2pp

5Y CAGR+17.4pp

10Y CAGR-7.7pp

Brighthouse's net profit margin was 4.9% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.2 percentage points from the prior year.

Return on Equity

4.9%

YoY-0.9pp

5Y CAGR+10.8pp

10Y CAGR-1.8pp

Brighthouse's ROE was 4.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.9 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$102.0M

YoY-59.2%

5Y CAGR-26.4%

Brighthouse spent $102.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 59.2% from the prior year.

Capital Expenditures

N/A

BHFAL Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$6.8B+43.2%	$4.7B+14.7%	$4.1B-40.1%	$6.9B+38.1%	$5.0B-41.5%	$8.5B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$449.0M+10.0%	$408.0M-2.4%	$418.0M+19.1%	$351.0M-8.8%	$385.0M+11.3%	$346.0M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$152.0M0.0%	$152.0M-0.7%	$153.0M0.0%	$153.0M-6.1%	$163.0M-11.4%	$184.0M
Income Tax	$36.0M+24.1%	$29.0M+107.9%	-$367.0M-143.3%	$848.0M+134.9%	$361.0M+199.4%	-$363.0M
Net Income	$331.0M+15.7%	$286.0M+123.6%	-$1.2B-132.2%	$3.8B+142.9%	$1.6B+246.5%	-$1.1B
EPS (Diluted)	$5.71+23.1%	$4.64+125.2%	$-18.39-135.8%	$51.30+179.0%	$18.39+258.8%	$-11.58

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$1.5B-9.6%	$1.7B-7.0%	$1.8B+108.5%	$871.0M-63.6%	$2.4B+98.3%	$1.2B-40.3%	$2.0B+41.4%	$1.4B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$114.0M-1.7%	$116.0M+16.0%	$100.0M-2.9%	$103.0M-20.8%	$130.0M+38.3%	$94.0M-7.8%	$102.0M+1.0%	$101.0M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$38.0M0.0%	$38.0M0.0%	$38.0M0.0%	$38.0M0.0%	$38.0M0.0%	$38.0M0.0%	$38.0M0.0%	$38.0M
Income Tax	-$222.0M-1950.0%	$12.0M-88.5%	$104.0M+1200.0%	$8.0M+109.1%	-$88.0M-154.3%	$162.0M+1520.0%	$10.0M+150.0%	-$20.0M
Net Income	-$766.0M-2288.6%	$35.0M-92.7%	$479.0M+463.5%	$85.0M+131.7%	-$268.0M-147.1%	$569.0M+223.3%	$176.0M+417.6%	$34.0M
EPS (Diluted)	$-13.82	N/A	$7.89+673.5%	$1.02+120.2%	$-5.04	N/A	$2.47+1958.3%	$0.12

BHFAL Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$241.8B+1.4%	$238.5B+0.9%	$236.3B+5.1%	$224.8B-14.3%	$262.3B+5.8%	$247.9B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$5.4B+6.8%	$5.0B+31.0%	$3.9B-6.4%	$4.1B-8.0%	$4.5B+8.9%	$4.1B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$235.0B+0.6%	$233.5B+0.9%	$231.3B+5.5%	$219.2B-13.6%	$253.8B+10.5%	$229.8B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$3.2B0.0%	$3.2B0.0%	$3.2B0.0%	$3.2B0.0%	$3.2B-8.1%	$3.4B
Total Equity	$6.8B+36.5%	$5.0B+0.3%	$4.9B-10.7%	$5.5B-65.7%	$16.1B-10.4%	$18.0B
Retained Earnings	-$686.0M+38.7%	-$1.1B+25.7%	-$1.5B-281.5%	-$395.0M+90.8%	-$4.3B-700.4%	-$534.0M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$236.8B-2.1%	$241.8B-1.2%	$244.7B+0.8%	$242.6B+3.4%	$234.7B-1.6%	$238.5B-2.7%	$245.2B+3.3%	$237.4B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$4.9B-8.9%	$5.4B-18.5%	$6.6B+19.2%	$5.5B+18.7%	$4.7B-7.5%	$5.0B-10.4%	$5.6B+26.8%	$4.4B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$231.2B-1.6%	$235.0B-1.4%	$238.3B+0.6%	$236.9B+3.3%	$229.4B-1.8%	$233.5B-2.5%	$239.6B+2.7%	$233.2B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$3.2B0.0%	$3.2B0.0%	$3.2B0.0%	$3.2B0.0%	$3.2B0.0%	$3.2B0.0%	$3.2B0.0%	$3.2B
Total Equity	$5.6B-17.8%	$6.8B+6.4%	$6.4B+12.2%	$5.7B+8.3%	$5.2B+5.6%	$5.0B-10.2%	$5.5B+33.4%	$4.1B
Retained Earnings	-$1.5B-111.7%	-$686.0M+16.6%	-$823.0M+36.8%	-$1.3B+6.1%	-$1.4B-23.9%	-$1.1B+37.5%	-$1.8B+9.0%	-$2.0B

BHFAL Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$259.0M+189.3%	-$290.0M-111.7%	-$137.0M+88.8%	-$1.2B-291.6%	$641.0M-27.8%	$888.0M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$751.0M+134.2%	-$2.2B+31.4%	-$3.2B+61.4%	-$8.3B+32.4%	-$12.2B-109.4%	-$5.8B
Financing Cash Flow	-$668.0M-118.2%	$3.7B+19.8%	$3.1B-66.4%	$9.1B-23.6%	$12.0B+93.4%	$6.2B
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$102.0M-59.2%	$250.0M0.0%	$250.0M-48.8%	$488.0M-2.2%	$499.0M+5.5%	$473.0M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$221.0M-7266.7%	-$3.0M-102.6%	$117.0M+11800.0%	-$1.0M-100.7%	$146.0M+223.7%	-$118.0M-591.7%	$24.0M-92.8%	$334.0M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$485.0M+62.6%	-$1.3B-194.5%	$1.4B+1125.0%	$112.0M-80.1%	$563.0M+257.7%	-$357.0M-174.6%	-$130.0M+88.0%	-$1.1B
Financing Cash Flow	$226.0M+182.5%	$80.0M+118.9%	-$423.0M-155.5%	$762.0M+170.1%	-$1.1B-888.2%	-$110.0M-108.5%	$1.3B-5.2%	$1.4B
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$0	$0	$0-100.0%	$43.0M-27.1%	$59.0M-1.7%	$60.0M-6.3%	$64.0M0.0%	$64.0M

BHFAL Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	4.9%-1.2pp	6.0%+35.5pp	-29.5%-84.4pp	54.9%+23.7pp	31.2%+43.7pp	-12.5%
Return on Equity	4.9%-0.9pp	5.8%+30.3pp	-24.6%-92.8pp	68.2%+58.6pp	9.6%+15.5pp	-5.9%
Return on Assets	0.1%+0.0pp	0.1%+0.6pp	-0.5%-2.2pp	1.7%+1.1pp	0.6%+1.0pp	-0.4%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.47-0.2	0.640.0	0.64+0.1	0.57+0.4	0.200.0	0.19
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-50.2%-52.2pp	2.1%-24.3pp	26.4%+16.6pp	9.8%+21.0pp	-11.2%-58.4pp	47.2%+38.5pp	8.7%+6.3pp	2.4%
Return on Equity	-13.8%-14.3pp	0.5%-7.0pp	7.5%+6.0pp	1.5%+6.6pp	-5.1%-16.6pp	11.5%+8.3pp	3.2%+2.4pp	0.8%
Return on Assets	-0.3%-0.3pp	0.0%-0.2pp	0.2%+0.2pp	0.0%+0.1pp	-0.1%-0.3pp	0.2%+0.2pp	0.1%+0.1pp	0.0%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.57+0.1	0.47-0.0	0.50-0.1	0.56-0.0	0.60-0.0	0.64+0.1	0.57-0.2	0.76
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Frequently Asked Questions

What is Brighthouse's annual revenue?

Brighthouse (BHFAL) reported $6.8B in total revenue for fiscal year 2025. This represents a 43.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Brighthouse's revenue growing?

Brighthouse (BHFAL) revenue grew by 43.2% year-over-year, from $4.7B to $6.8B in fiscal year 2025.

Is Brighthouse profitable?

Yes, Brighthouse (BHFAL) reported a net income of $331.0M in fiscal year 2025, with a net profit margin of 4.9%.

How much debt does Brighthouse have?

As of fiscal year 2025, Brighthouse (BHFAL) had $5.4B in cash and equivalents against $3.2B in long-term debt.

What is Brighthouse's net profit margin?

Brighthouse (BHFAL) had a net profit margin of 4.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Brighthouse's return on equity (ROE)?

Brighthouse (BHFAL) has a return on equity of 4.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Brighthouse's operating cash flow?

Brighthouse (BHFAL) generated $259.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Brighthouse's total assets?

Brighthouse (BHFAL) had $241.8B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Brighthouse buy back shares?

Yes, Brighthouse (BHFAL) spent $102.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Brighthouse have outstanding?

Brighthouse (BHFAL) had 57M shares outstanding as of fiscal year 2025.

What is Brighthouse's debt-to-equity ratio?

Brighthouse (BHFAL) had a debt-to-equity ratio of 0.47 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Brighthouse's return on assets (ROA)?

Brighthouse (BHFAL) had a return on assets of 0.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Brighthouse's Piotroski F-Score?

Brighthouse (BHFAL) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Brighthouse's earnings high quality?

Brighthouse (BHFAL) has an earnings quality ratio of 0.78x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Brighthouse?

Brighthouse (BHFAL) scores 30 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.